{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:28:19Z","timestamp":1791930499620,"version":"4.3.4"},"reference-count":105,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:p>The pathogenesis of pre-eclampsia is still not completely known; however, in the recent decade, there have been tremendous research efforts leading to impressive results highlighting the role of a disturbed angiogenic balance as one of the key features of the disease. Numerous studies have shown the key role of the placenta in the pathogenesis of pre-eclampsia. A shift in the sFlt-1 (soluble Fms-like tyrosine kinase-1)\/PlGF (placental growth factor) ratio is associated with the disease. Although pre-eclampsia seems to be a clearly defined disease, clinical presentation, and particularly the dynamics of the clinical course, can vary enormously. The only available tools to diagnose pre-eclampsia are blood pressure measurement and urine protein sampling. However, these tools have a low sensitivity and specificity regarding the prediction of the course of the disease or maternal and perinatal outcomes. The only cure for the disease is delivery, although a timely diagnosis helps in decreasing maternal and fetal morbidity and mortality. The sFlt1\/PlGF ratio is able to give additional valuable information on the status and progression of the disease and is apt to be implemented in the diagnostic algorithm of pre-eclampsia. In the present review, we aim to provide an overview of the vast literature on angiogenesis and anti-angiogenesis factors in pre-eclampsia that have been published over the last decade. We introduce work from basic research groups who have focused on the pathophysiological basis of the disease. Furthermore, we review studies with a clinical focus in which the sFlt-1\/PlGF ratio has been analysed along with other candidates for routine clinical assessment of pre-eclampsia.<\/jats:p>","DOI":"10.1042\/cs20110097","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T11:41:08Z","timestamp":1316518868000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia"],"prefix":"10.1042","volume":"122","author":[{"given":"Stefan","family":"Verlohren","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Campus Virchow Clinic, Charit\u00e9 University Medicine Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stepan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Hospital Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 Medical Faculty\/Max-Delbrueck Center for Molecular Medicine, Berlin, Germany"},{"name":"HELIOS-Clinic Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"2021113010202148700_B1","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens. Pregnancy"},{"key":"2021113010202148700_B2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"2021113010202148700_B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"2021113010202148700_B4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ajog.2006.02.012","article-title":"Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy","volume":"195","author":"Ganzevoort","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B5","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"2021113010202148700_B6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"2021113010202148700_B7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0897.1997.tb00519.x","article-title":"Vascular endothelial growth factor is increased in patients with preeclampsia","volume":"38","author":"Kupferminc","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"key":"2021113010202148700_B8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"2021113010202148700_B9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","article-title":"Preeclampsia is associated with reduced serum levels of placenta growth factor","volume":"179","author":"Torry","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2021113010202148700_B11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021113010202148700_B12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2021113010202148700_B13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"Schiettecatte","year":"2010","journal-title":"Clin. Biochem."},{"key":"2021113010202148700_B14","doi-asserted-by":"crossref","first-page":"161 e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B15","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume-title":"Am. J. Obstet. Gynecol.","author":"Sunderji","year":"2009"},{"key":"2021113010202148700_B16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/path.1700930219","article-title":"The pathological response of the vessels of the placental bed to hypertensive pregnancy","volume":"93","author":"Robertson","year":"1967","journal-title":"J. Pathol. Bacteriol"},{"key":"2021113010202148700_B17","first-page":"177","article-title":"The role of the spiral arteries in the pathogenesis of preeclampsia","volume":"1","author":"Brosens","year":"1972","journal-title":"Obstet. Gynecol. Annu."},{"key":"2021113010202148700_B18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00316301","article-title":"The fetal vascularisation of term human placental villi. II. Intermediate and terminal villi","volume":"173","author":"Kaufmann","year":"1985","journal-title":"Anat. Embryol."},{"key":"2021113010202148700_B19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00707305","article-title":"The fetal vascularisation of term human placental villi","volume":"173","author":"Leiser","year":"1985","journal-title":"I. Peripheral stem villi. Anat. Embryol."},{"key":"2021113010202148700_B20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.277.5332.1669","article-title":"Regulation of human placental development by oxygen tension","volume":"277","author":"Genbacev","year":"1997","journal-title":"Science"},{"key":"2021113010202148700_B21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-0378(98)00022-9","article-title":"Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia","volume":"39","author":"Zhou","year":"1998","journal-title":"J. Reprod. Immunol."},{"key":"2021113010202148700_B22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"2021113010202148700_B23","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021113010202148700_B24","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"2021113010202148700_B25","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol"},{"key":"2021113010202148700_B26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/plac.2002.0893","article-title":"Impaired oxygen-dependent reduction of HIF-1\u03b1 and -2\u03b1 proteins in pre-eclamptic placentae","volume":"24","author":"Rajakumar","year":"2003","journal-title":"Placenta"},{"key":"2021113010202148700_B27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI8316","article-title":"Hypoxiainducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF\u03b23","volume":"105","author":"Caniggia","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2021113010202148700_B28","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am. J. Physiol. Regul","volume":"291","author":"Nevo","year":"2006","journal-title":"Integr. Comp. Physiol."},{"key":"2021113010202148700_B29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/plac.1999.0427","article-title":"The effects of angiogenic growth factors on extravillous trophoblast invasion and motility","volume":"20","author":"Lash","year":"1999","journal-title":"Placenta"},{"key":"2021113010202148700_B30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/plac.2002.0923","article-title":"Vascular endothelial growth factor is a chemoattractant for trophoblast cells","volume":"24","author":"Lash","year":"2003","journal-title":"Placenta"},{"key":"2021113010202148700_B31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/107155760100800606","article-title":"Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro","volume":"8","author":"Crocker","year":"2001","journal-title":"J. Soc. Gynecol. Investig."},{"key":"2021113010202148700_B32","first-page":"1101","article-title":"VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia","volume":"79","author":"Brockelsby","year":"1999","journal-title":"Lab. Invest."},{"key":"2021113010202148700_B33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1471-0528.2000.tb11586.x","article-title":"Plasma from women with pre-eclampsia induces an in vitro alteration in the endotheliumdependent behaviour of myometrial resistance arteries","volume":"107","author":"Hayman","year":"2000","journal-title":"Br. J. Obstet. Gyncaecol."},{"key":"2021113010202148700_B34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"2021113010202148700_B35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int."},{"key":"2021113010202148700_B36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/CIRCRESAHA.108.171504","article-title":"A novel human-specific soluble vascular endothelial growth factor receptor 1: cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia","volume":"102","author":"Sela","year":"2008","journal-title":"Circ. Res."},{"key":"2021113010202148700_B37","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1210\/jc.2009-0017","article-title":"A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia","volume":"94","author":"Thomas","year":"2009","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"2021113010202148700_B38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","article-title":"The discovery of the placental growth factor and its role in angiogenesis: a historical review","volume":"11","author":"Ribatti","year":"2008","journal-title":"Angiogenesis"},{"key":"2021113010202148700_B39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.placenta.2010.01.011","article-title":"Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model","volume":"31","author":"Geusens","year":"2010","journal-title":"Placenta"},{"key":"2021113010202148700_B40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/HYPERTENSIONAHA.110.153163","article-title":"Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy","volume":"56","author":"Verlohren","year":"2010","journal-title":"Hypertension"},{"key":"2021113010202148700_B41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.placenta.2004.09.007","article-title":"Endovascular trophoblast invasion and associated structural changes in uterine spiral arteries of the pregnant rat","volume":"26","author":"Caluwaerts","year":"2005","journal-title":"Placenta"},{"key":"2021113010202148700_B42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20080270","article-title":"Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia","volume":"116","author":"Bills","year":"2009","journal-title":"Clin. Sci."},{"key":"2021113010202148700_B43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/CS20050292","article-title":"The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term","volume":"110","author":"Bates","year":"2006","journal-title":"Clin. Sci."},{"key":"2021113010202148700_B44","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.108.120576","article-title":"Autoantibodies to the angiotensin type\u00a0I receptor in response to placental ischemia and tumor necrosis factor \u03b1 in pregnant rats","volume":"52","author":"Lamarca","year":"2008","journal-title":"Hypertension"},{"key":"2021113010202148700_B45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"key":"2021113010202148700_B46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type\u00a01-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2021113010202148700_B47","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2021113010202148700_B48","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.0000058200.90059.B1","article-title":"AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase","volume":"107","author":"Dechend","year":"2003","journal-title":"Circulation"},{"key":"2021113010202148700_B49","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","article-title":"AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor","volume":"101","author":"Dechend","year":"2000","journal-title":"Circulation"},{"key":"2021113010202148700_B50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.HYP.0000257797.49289.71","article-title":"Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia","volume":"49","author":"Herse","year":"2007","journal-title":"Hypertension"},{"key":"2021113010202148700_B51","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1172\/JCI107462","article-title":"A study of angiotensin II pressor response throughout primigravid pregnancy","volume":"52","author":"Gant","year":"1973","journal-title":"J. Clin. Invest."},{"key":"2021113010202148700_B52","first-page":"208","article-title":"Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy","volume":"18","author":"Baylis","year":"1998","journal-title":"Semin. Nephrol."},{"key":"2021113010202148700_B53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nm.1856","article-title":"Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice","volume":"14","author":"Zhou","year":"2008","journal-title":"Nat. Med."},{"key":"2021113010202148700_B54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/HYPERTENSIONAHA.107.097790","article-title":"Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type\u00a01 receptor and calcineurin\/nuclear factor of activated T-cells signaling","volume":"51","author":"Zhou","year":"2008","journal-title":"Hypertension"},{"key":"2021113010202148700_B55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/HYPERTENSIONAHA.107.103176","article-title":"Uterine vascular function in a transgenic preeclampsia rat model","volume":"51","author":"Verlohren","year":"2008","journal-title":"Hypertension"},{"key":"2021113010202148700_B56","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajh\/4.8.700","article-title":"Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia","volume":"4","author":"Roberts","year":"1991","journal-title":"Am. J. Hypertens"},{"key":"2021113010202148700_B58","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"key":"2021113010202148700_B59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2021113010202148700_B60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2005080810","article-title":"Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival","volume":"17","author":"Eremina","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010202148700_B61","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.ATV.0000030186.66672.36","article-title":"Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor\/vascular endothelial growth factor receptor pathway in cancer patients","volume":"22","author":"Kuenen","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010202148700_B62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2021113010202148700_B63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0143-4004(97)80061-6","article-title":"Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery","volume":"18","author":"Lyall","year":"1997","journal-title":"Placenta"},{"key":"2021113010202148700_B64","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-0528.1996.tb09627.x","article-title":"VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia","volume":"103","author":"Cooper","year":"1996","journal-title":"Br. J. Obstet. Gynaecol"},{"key":"2021113010202148700_B65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mob.2001.108342","article-title":"Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance","volume":"184","author":"Bosio","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B66","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0029-7844(95)00259-T","article-title":"Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia","volume":"86","author":"Baker","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"2021113010202148700_B67","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1067\/mob.2000.108022","article-title":"Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia","volume":"183","author":"Livingston","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1471-0528.1997.tb11050.x","article-title":"Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia","volume":"104","author":"Lyall","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"2021113010202148700_B69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia","volume":"106","author":"Reuvekamp","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"2021113010202148700_B70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.earlhumdev.2005.09.010","article-title":"Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates","volume":"82","author":"Boutsikou","year":"2006","journal-title":"Early Hum. Dev."},{"key":"2021113010202148700_B72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1155\/MI.2005.293","article-title":"Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates","volume":"2005","author":"Malamitsi-Puchner","year":"2005","journal-title":"Mediators Inflamm."},{"key":"2021113010202148700_B73","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","article-title":"Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-forgestational-age neonates: relationship to circulating placental growth factor","volume":"90","author":"Shibata","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010202148700_B74","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jc.2005-1076","article-title":"Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation","volume":"91","author":"Wath\u00e9n","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010202148700_B75","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14767050600922677","article-title":"A role of the anti-angiogenic factor sVEGFR-1 in the \u2018mirror syndrome\u2019 (Ballantyne's syndrome)","volume":"19","author":"Espinoza","year":"2006","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B76","doi-asserted-by":"crossref","first-page":"382 e1","DOI":"10.1016\/j.ajog.2008.02.016","article-title":"Twin-to-twin transfusion syndrome: an antiangiogenic state?","volume":"198","author":"Kusanovic","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.AOG.0000216014.72503.09","article-title":"Circulating angiogenic factors and placental abruption","volume":"108","author":"Signore","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"2021113010202148700_B78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14767050701413022","article-title":"Unexplained fetal death: another anti-angiogenic state","volume":"20","author":"Espinoza","year":"2007","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B79","first-page":"S14","article-title":"Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation","volume":"42","author":"Harrington","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113010202148700_B80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/uog.2676","article-title":"Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free \u03b2-human chorionic gonadotropin, activin A and inhibin A at 22+0 to 24+6\u00a0weeks' gestation","volume":"27","author":"Spencer","year":"2006","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113010202148700_B81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/jmf.12.2.78.88","article-title":"Second-trimester uterine artery Doppler screening in unselected populations: a review","volume":"12","author":"Papageorghiou","year":"2002","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1471-0528.2000.tb11690.x","article-title":"How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and perinatal death?","volume":"107","author":"Chien","year":"2000","journal-title":"An overview. Br. J. Obstet. Gynecol."},{"key":"2021113010202148700_B83","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajog.2005.02.109","article-title":"Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction","volume":"193","author":"Parra","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B84","doi-asserted-by":"crossref","first-page":"175 e1","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113010202148700_B86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"2021113010202148700_B87","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010202148700_B88","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2008.06.069","article-title":"First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for lateonset preeclampsia","volume":"199","author":"Baumann","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B89","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pd.2433","article-title":"Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13\u00a0weeks of gestation in preeclampsia","volume":"30","author":"Akolekar","year":"2010","journal-title":"Prenat. Diagn."},{"key":"2021113010202148700_B90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jri.2009.09.001","article-title":"Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia: a step forward but not the definitive answer","volume":"82","author":"Foidart","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"2021113010202148700_B91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B92","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"2021113010202148700_B93","doi-asserted-by":"crossref","first-page":"244.e1","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajog.2004.12.052","article-title":"Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia","volume":"192","author":"Buhimschi","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B95","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B96","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"2021113010202148700_B97","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","journal-title":"Obstet. Gynecol."},{"key":"2021113010202148700_B98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004227.pub3","article-title":"Antioxidants for preventing pre-eclampsia","volume-title":"Cochrane Database Syst. Rev. CD004227","author":"Rumbold","year":"2008"},{"key":"2021113010202148700_B99","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1095\/biolreprod.110.088351","article-title":"Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy","volume":"84","author":"Williams","year":"2011","journal-title":"Biol. Reprod."},{"key":"2021113010202148700_B100","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1067\/mob.2000.107357","article-title":"Association between level of delivery hospital and neonatal outcomes among South Carolina Medicaid recipients","volume":"183","author":"Sanderson","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B101","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1067\/mob.2001.114484","article-title":"Perinatal regionalization and neonatal mortality in North Carolina, 1968\u20131994","volume":"184","author":"Bode","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113010202148700_B102","first-page":"95","article-title":"American College of Obstetricians and Gynecologists","volume":"78","author":"Committee on Obstetric Practice Antenatal corticosteroid therapy for fetal maturation","year":"2002","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"2021113010202148700_B103","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebocontrolled trial","volume":"359","author":"Duley","year":"2002","journal-title":"Lancet"},{"key":"2021113010202148700_B104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(00)03599-6","article-title":"Primary, secondary, and tertiary prevention of pre-eclampsia","volume":"357","author":"Dekker","year":"2001","journal-title":"Lancet"},{"key":"2021113010202148700_B105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3111\/13696998.2010.535285","article-title":"Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective","volume":"13","author":"Hadker","year":"2010","journal-title":"J. Med. Econ."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/122\/2\/43\/441158\/cs1220043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/122\/2\/43\/441158\/cs1220043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:42:53Z","timestamp":1638268973000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/122\/2\/43\/68953\/Angiogenic-growth-factors-in-the-diagnosis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20110097","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}